PolyU and CUHK academics develop new drug to treat multiple obesity-related metabolic diseases
Prof. Thomas Leung Yun-chung, Professor of PolyU’s Department of Applied Biology and Chemical Technology and Prof. Alisa Shum Sau-wun, Associate Professor of the School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK), have developed a first-in-class drug, ABarginase, for treatment of multiple obesity-related metabolic diseases. The drug is an albumin-binding recombinant human arginase that is engineered using an advanced fusion protein strategy. This allows for an inexpensive and highly efficient fabrication process, making ABarginase affordable and widely adoptable for clinical applications. (Oriental Daily News A04, Hong Kong Economic Journal A08, Hong Kong Economic Times A14, Sky Post P05, Ta Kung Pao A08, Wen Wei Po A06, Lion Rock Daily P01)
Press release:
English | Chinese
Online coverage:
TVB
https://polyu.me/3BME1oI
Now TV
https://polyu.me/3ITxVa7
i-Cable
https://polyu.me/43ipRY5
RTHK
https://polyu.me/45gniHX
https://polyu.me/3nBfTOH
Metro Radio
https://polyu.me/3WnA3wd
AM730
https://polyu.me/45lSpSk
Ming Pao Daily News
https://polyu.me/3OyojoF
Oriental Daily News
https://polyu.me/3MLmSSp
Hong Kong Economic Journal
https://polyu.me/3OvqIR9 (subscription required)
Sky Post
https://polyu.me/3od1FHS
Ta Kung Pao
https://polyu.me/42TyY1u
Wen Wei Po
https://polyu.me/3MMrCr2
China Daily (Hong Kong Edition)
https://polyu.me/3q38coY
Bastille Post
https://polyu.me/3pZAqkn
Dot Dot News
https://polyu.me/3OumXLy
Line Today
https://polyu.me/43dtcYo
Medical Express
https://polyu.me/3IyHH11
Mirage News
https://polyu.me/3pRYh5p
Yahoo HK
https://polyu.me/3pWbUR7